Balyasny Asset Management’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30.3M | Buy |
361,605
+344,273
| +1,986% | +$28.8M | 0.05% | 394 |
|
2025
Q1 | $1.24M | Sell |
17,332
-243,993
| -93% | -$17.4M | ﹤0.01% | 1287 |
|
2024
Q4 | $11.7M | Buy |
+261,325
| New | +$11.7M | 0.02% | 634 |
|
2024
Q3 | – | Sell |
-247,214
| Closed | -$10.1M | – | 2329 |
|
2024
Q2 | $10.1M | Buy |
247,214
+95,596
| +63% | +$3.9M | 0.02% | 637 |
|
2024
Q1 | $6.49M | Sell |
151,618
-775,258
| -84% | -$33.2M | 0.01% | 800 |
|
2023
Q4 | $37.3M | Buy |
926,876
+468,053
| +102% | +$18.8M | 0.07% | 262 |
|
2023
Q3 | $13.5M | Buy |
+458,823
| New | +$13.5M | 0.03% | 536 |
|